Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults With Generalized Anxiety Disorder.

Cephalon

Overview

A 12-Month, Open-Label, Flexible-Dosage Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults with Generalized Anxiety Disorder.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Conditions

Anxiety Disorders

Interventions

GabitrilDRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 64 Years

Medical Language ↔ Plain English

Subjects who have completed 10 weeks of double-blind treatment and the subsequent taper period in 1 of the 3 previous double-blind studies (studies C6671/3030/AX/US, C6671/3031/AX/US, or C6671/3032/AX/US).

Locations (93)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Birmingham Research Group

Birmingham, Alabama, United States

Pivotal Research Center

Mesa, Arizona, United States

Pivotal Research

Peoria, Arizona, United States

Southwestern Research

Beverly Hills, California, United States

Valley Clinical Research

El Centro, California, United States

Irvine Center for Clinical Res

Irvine, California, United States

Pharmacology Research Institute

Los Alamitos, California, United States

Pacific Institue for Medical

Los Angeles, California, United States

Pharmacology Research Institute

Newport Beach, California, United States

Pacific Clinical Research Medi

Orange, California, United States

...and 83 more locations